scispace - formally typeset
N

Naomi Moris

Researcher at University of Cambridge

Publications -  25
Citations -  1437

Naomi Moris is an academic researcher from University of Cambridge. The author has contributed to research in topics: Embryonic stem cell & Biology. The author has an hindex of 11, co-authored 19 publications receiving 818 citations. Previous affiliations of Naomi Moris include Francis Crick Institute.

Papers
More filters
Journal ArticleDOI

Transition states and cell fate decisions in epigenetic landscapes

TL;DR: Here, focusing strictly on the fate decision events, it is suggested that fate transitions occur in a discontinuous, stochastic manner whereby signals modulate the probability of the transition events.
Journal ArticleDOI

Multi-axial self-organization properties of mouse embryonic stem cells into gastruloids

TL;DR: It is shown that small aggregates of mouse embryonic stem cells, when stimulated to undergo gastrulation-like events and elongation in vitro, can organize a post-occipital pattern of neural, mesodermal and endodermal derivatives that mimic embryonic spatial and temporal gene expression.
Journal ArticleDOI

An in vitro model of early anteroposterior organization during human development

TL;DR: This study shows that human embryonic stem cells can be used to generate gastruloids—three-dimensional multicellular aggregates that differentiate to form derivatives of the three germ layers organized spatiotemporally, without additional extra-embryonic tissues.
Journal ArticleDOI

Single-cell and spatial transcriptomics reveal somitogenesis in gastruloids

TL;DR: The power of gastruloids as a model system for exploring development and somitogenesis in vitro in a high-throughput manner is shown, as it can be induced to generate somites with the correct rostral–caudal patterning.
Journal ArticleDOI

Histone Acetyltransferase KAT2A Stabilizes Pluripotency with Control of Transcriptional Heterogeneity

TL;DR: Evidence is shown of a relationship between transcriptional heterogeneity and cell fate transitions through manipulation of the histone acetylation landscape of mouse embryonic stem cells, suggesting a general principle that could be exploited in other normal and malignant stem cell fate transitioned.